Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study

BACKGROUND: In Malaysia, the treatment for chronic myeloid leukemia (CML) has long been delivered under the Malaysian Patient Assistance Program (MYPAP), but research on identifying factors contributing to non-adherence to tyrosine kinase inhibitors (TKIs) is still limited. The current study explore...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Lim, Yik Ming, Eng, Wei Lerk, Chan, Huan Keat
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648400/
https://ncbi.nlm.nih.gov/pubmed/28749622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.7.1925
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars